Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
about
Neuropharmacology of vestibular system disordersThe effect of transdermal scopolamine for the prevention of postoperative nausea and vomitingTransdermal delivery of scopolamine by natural submicron injectors: in-vivo study in pigScopolamine administration modulates muscarinic, nicotinic and NMDA receptor systemsSerum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.GABAergic but not anti-cholinergic agents re-induce clinical deficits after strokeCombined scopolamine and ethanol treatment results in a locomotor stimulant response suggestive of synergism that is not blocked by dopamine receptor antagonists.The effect of transdermal scopolamine plus intravenous dexamethasone for the prevention of postoperative nausea and vomiting in patients with epidural PCA after major orthopedic surgery.Cholinergic modulation of working memory activity in primate prefrontal cortex.Triple Therapy with Scopolamine, Ondansetron, and Dexamethasone for Prevention of Postoperative Nausea and Vomiting in Moderate to High-Risk Patients Undergoing Craniotomy Under General Anesthesia: A Pilot StudyUnexpected anterograde amnesia associated with Buscopan used as a predmedication for endocscopyEffect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesisEffect of Scopolamine Patch Use on Postoperative Voiding Function After Transobturator Slings.Muscarinic acetylcholine receptors as effector sites for present and future therapeutic applications: focus on non-neural cholinergic systems.Anticholinergics in palliative medicine: an update.Safety and efficacy of commonly used antiemetics.Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?Motion Sickness: Current Knowledge and Recent Advance.Evaluation of hyoscine N-butyl bromide efficacy on the prevention of catheter-related bladder discomfort after transurethral resection of prostate: a randomized, double-blind control trial.The ethnobotany of psychoactive plant use: a phylogenetic perspective.Anticholinergic syndrome following an unintentional overdose of scopolamine.Medications influencing central cholinergic neurotransmission affect saccadic and smooth pursuit eye movements in healthy young adults.Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.Model-based exposure-response analysis to quantify age related differences in the response to scopolamine in healthy subjectsLipid oxidation inhibitory effects and phenolic composition of aqueous extracts from medicinal plants of Colombian Amazonia.A Distress Protocol for Respiratory Emergencies in Terminally Ill Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease.Administration of Phytoceramide Enhances Memory and Upregulates the Expression of pCREB and BDNF in Hippocampus of Mice.The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.Epidemic of poisoning caused by scopolamine disguised as Rohypnol tablets.Acute effects of a low-dose atropine/scopolamine mixture as a food contaminant in human volunteers.Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.Impaired off-line consolidation of motor memories after combined blockade of cholinergic receptors during REM sleep-rich sleep.Histamine H1-receptor blockade in humans affects psychomotor performance but not memory.Tropane alkaloids (from Datura sp.) as undesirable substances in animal feed - Scientific Opinion of the Panel on Contaminants in the Food ChainScientific Opinion on Tropane alkaloids in food and feedCognition Enhancing and Neuromodulatory Propensity of Bacopa monniera Extract Against Scopolamine Induced Cognitive Impairments in Rat Hippocampus.Scopolamine attenuates auditory cortex response.Medications influencing central cholinergic pathways affect fixation stability, saccadic response time and associated eye movement dynamics during a temporally-cued visual reaction time task.Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.THE EFFECTS OF THE ALKALOID SCOPOLAMINE ON THE PERFORMANCE AND BEHAVIOR OF TWO CATERPILLAR SPECIES.
P2860
Q24624927-340FA1B6-4D59-477F-9B96-26847E8BD268Q27024146-9CE6DF21-AF4E-4C31-A120-8DBEE020BF76Q28481022-0109FB6F-B4D0-4FCB-947E-1A9C9556FEA5Q28481245-BC816F2E-A8EC-4C6A-9CEE-EA84C419FA80Q33369568-EE6144E2-0774-49FC-9D78-3D0A90D4AE74Q33767908-930EED1E-FAFC-451F-B02E-C765A6F24734Q33800979-B280D244-C187-4520-A4E2-2A7F1A6C8708Q33861687-7873ED7D-9316-47EF-982C-9E3B4267BE0BQ35543969-D16D9720-A6B8-4559-811B-9DB3DFE3A41BQ35747254-AFF6EA2C-9CF3-437A-8F41-89FA8EE02611Q36178016-DBCBD116-B22C-440C-A8A2-92A8AF4D8665Q36758312-0371F4E2-E2A0-44E1-A18C-DA7F5141F8FCQ36840222-207753D5-24B3-4C27-9E93-EE245DDC8F69Q37689776-2366417A-73ED-40C5-A7A8-56138284ACC9Q38042243-5AA2287E-64C2-4E14-A2AC-773C1922DA2FQ38570496-AB82523F-0CAA-4E1B-BF54-003171C4F722Q38583153-6FD322CE-07E1-40F0-8E6F-93E1995C7E1DQ38603260-2B6F92F9-8B3D-4CFB-B503-1B449F8D75F8Q39151354-9C0449C6-190F-4417-8301-50DFB72F73E8Q39269259-F1B9ABE4-273E-416F-A0C2-589CB3A19750Q39298234-4AF39E90-9216-45A8-A3FE-1E93BB4AE3E5Q39348593-253AD9EF-B650-49F1-BDA8-7E5F45B30809Q39784796-CE41B50D-2C49-4587-913C-8BB5922A96E9Q41634921-DEAFD116-4FDF-4470-A0E8-D5FF5E4E2C83Q41839882-EF6EEFC7-4ACB-4B32-840B-DF405D1DECC7Q41952889-A9542D89-E5E3-423B-91EE-6E2F1EAB871DQ42182663-1BD2089A-6C3B-4CC3-82E7-1154AD49102CQ43168345-6E570901-0951-4B0B-96AB-1ED48355A5AFQ43263313-A775968E-4573-4DE6-BADE-34380FBEC629Q45391472-35F1A806-0951-47DA-AA16-6EB346F48720Q45935490-990E1C32-C7F7-4347-883A-1D1515EA430EQ46133007-6326BE7B-A3E1-486C-86CB-F13A542E737CQ46798714-BB26F959-B927-4DAE-84C3-0409165D6580Q47145628-7E4986E4-CF03-47BA-997A-3F1DC47F40D0Q47153756-54F3EF5B-FF9F-4F7A-B776-61879482176EQ47587937-ABF9211E-C251-47DA-936D-EB1FB9A4A107Q48094100-D5C78339-B000-4948-AE0E-ED71EF50A0E6Q48583477-D93B0F79-5D2A-4365-B15F-53A274F72D41Q48763889-3434B59F-2B34-4F27-BEBA-A499D9840AE8Q50073472-A28174B0-328F-454E-9B14-10B78FDD012D
P2860
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@ast
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@en
type
label
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@ast
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@en
prefLabel
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@ast
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@en
P2093
P1476
Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.
@en
P2093
Reinhard Oertel
Ulf D Renner
Wilhelm Kirch
P304
P356
10.1097/01.FTD.0000168293.48226.57
P577
2005-10-01T00:00:00Z